Cargando…

Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine)

BACKGROUND: Impaired walking capacity is a frequent confinement in Multiple Sclerosis (MS). Patients are affected by limitations in coordination, walking speed and the distance they may cover. Also abnormal dynamic walking patterns have been reported, involving continuous deceleration over time. Fam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keune, Philipp M., Cocks, Adam J., Young, William R., Burschka, Janina M., Hansen, Sascha, Hofstadt-van Oy, Ulrich, Oschmann, Patrick, Muenssinger, Jana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581460/ https://www.ncbi.nlm.nih.gov/pubmed/26400041 http://dx.doi.org/10.1186/s12883-015-0431-0

Ejemplares similares

An exploration of impaired walking dynamics and fatigue in Multiple Sclerosis
por: Burschka, Janina M, et al.
Publicado: (2012)

Mindfulness-based interventions in multiple sclerosis: beneficial effects of Tai Chi on balance, coordination, fatigue and depression
por: Burschka, Janina M, et al.
Publicado: (2014)

Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao’s Brief Repeatable Battery
por: Hansen, Sascha, et al.
Publicado: (2015)

Sustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function
por: Rabadi, Meheroz H., et al.
Publicado: (2013)

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial
por: Hupperts, Raymond, et al.
Publicado: (2016)

Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine
por: Sola-Valls, Núria, et al.
Publicado: (2018)

Fampridine and quality of life in individuals with multiple sclerosis
por: Sagawa, Yoshimasa, et al.
Publicado: (2016)

Wearable inertial sensors are highly sensitive in the detection of gait disturbances and fatigue at early stages of multiple sclerosis
por: Müller, Roy, et al.
Publicado: (2021)

Frontal brain activity and cognitive processing speed in multiple sclerosis: An exploration of EEG neurofeedback training
por: Keune, Philipp M., et al.
Publicado: (2019)

Mindfulness training during brief periods of hospitalization in multiple sclerosis (MS): beneficial alterations in fatigue and the mediating role of depression
por: Sauder, Torsten, et al.
Publicado: (2021)

Trait mindfulness is primarily associated with depression and not with fatigue in multiple sclerosis (MS): implications for mindfulness-based interventions
por: Sauder, Torsten, et al.
Publicado: (2021)

Managing HAM/TSP with Fampridine
por: Menna-Barreto, M Marcio
Publicado: (2014)

Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE
por: Hupperts, Raymond, et al.
Publicado: (2022)

Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine
por: Hobart, Jeremy, et al.
Publicado: (2018)

Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study
por: Castelnovo, Giovanni, et al.
Publicado: (2021)

Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting
por: Rodriguez-Leal, Francisco Alejandro, et al.
Publicado: (2019)

Clinical, Neurophysiological, and MRI Markers of Fampridine Responsiveness in Multiple Sclerosis—An Explorative Study
por: Mamoei, Sepehr, et al.
Publicado: (2021)

Central motor conduction time may predict response to fampridine in patients with multiple sclerosis
por: Zeller, D, et al.
Publicado: (2014)

The congruency of neuropsychological and F18-FDG brain PET/CT diagnostics of Alzheimer’s Disease (AD) in routine clinical practice: insights from a mixed neurological patient cohort
por: Hansen, Sascha, et al.
Publicado: (2022)

Stability of sensor-based gait parameters reassessed after a period of one year in people with multiple sclerosis
por: Müller, Roy, et al.
Publicado: (2023)

Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients
por: Moghadasi, Abdorreza Naser
Publicado: (2021)

Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting
por: Albrecht, Philipp, et al.
Publicado: (2018)

Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

Cortical Excitability Measures May Predict Clinical Response to Fampridine in Patients with Multiple Sclerosis and Gait Impairment
por: Ahdab, Rechdi, et al.
Publicado: (2019)

Evaluation of Prolonged Walking in Persons with Multiple Sclerosis: Reliability of the Spatio-Temporal Walking Variables during the 6-Minute Walk Test
por: Hadouiri, Nawale, et al.
Publicado: (2021)

Neuroprotective Properties of 4-Aminopyridine
por: Dietrich, Michael, et al.
Publicado: (2021)

Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test
por: Behrens, Janina, et al.
Publicado: (2014)

Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial
por: Kanhai, Kawita M. S., et al.
Publicado: (2019)

Maximum walking speed in multiple sclerosis assessed with visual perceptive computing
por: Grobelny, Anuschka, et al.
Publicado: (2017)

Ecological Validity of Walking Capacity Tests in Multiple Sclerosis
por: Stellmann, J. P., et al.
Publicado: (2015)

Waiting for ASCO to “Walk the Walk”
por: Fojo, Tito
Publicado: (2023)

Cognitive Contributors of Backward Walking in Persons with Multiple Sclerosis
por: Takla, Taylor N., et al.
Publicado: (2023)

SIX MINUTES WALKING IN POLIO SURVIVORS: EFFECTS ON FATIGUE AND WALKING ADAPTABILITY
por: TUIJTELAARS, Jana, et al.
Publicado: (2022)

Italian Validation of the 12-Item Multiple Sclerosis Walking Scale
por: Solaro, C., et al.
Publicado: (2015)

Gait Speed Trajectory During the Six-Minute Walk Test in Multiple Sclerosis: A Measure of Walking Endurance
por: Chen, Shanshan, et al.
Publicado: (2021)

Factors for Lower Walking Speed in Persons with Multiple Sclerosis
por: Nogueira, Leandro Alberto Calazans, et al.
Publicado: (2013)

Multiple Manifestations of Systemic Sclerosis Affect Walk Distance
por: Andréasson, Kristofer, et al.
Publicado: (2021)

Walking
Publicado: (1892)

Walking
Publicado: (1874)

Walking
Publicado: (1872)

Cannot write session to /tmp/vufind_sessions/sess_q83jrfptgd2j69c8vj9bj13oh1